Pentoxifylline Reduces Venular Leukocyte Adherence (“Reflow Paradox”) but Not Microvascular “No Reflow” in Hepatic Ischemia/Reperfusion
- 15 July 1997
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 71 (1), 1-6
- https://doi.org/10.1006/jsre.1997.5132
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- LIVER ISCHEMIA AND REPERFUSION INDUCES A SYSTEMIC INFLAMMATORY RESPONSE THROUGH KUPFFER CELL ACTIVATIONShock, 1996
- Pentoxifylline Attenuates the Depressed Endothelial Cell Function and Vascular Muscle Contractility following Trauma and Hemorrhagic ShockPublished by Wolters Kluwer Health ,1995
- PROTECTION BY PENTOXIFYLLINE AGAINST NORMOTHERMIC LIVER ISCHEMIA/REPERFUSION IN RATSTransplantation, 1995
- Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherenceSurgery, 1995
- Role of phosphodiesterases in the regulation of endothelial permeability in vitro.JCI Insight, 1993
- Contribution of No-reflow phenomenon to hepatic injury after ischemia-reperfusion: Evidence for a role for superoxide anionHepatology, 1992
- OXPENTIFYLLINE IN ENDOTOXAEMIAThe Lancet, 1989
- Rapid deformation of “passive” polymorphonuclear leukocytes: The effects of pentoxifyllineJournal of Cellular Physiology, 1989
- Quantitative analysis of microcirculatory disorders after prolonged ischemia in skeletal muscleZeitschrift für Die Gesamte Experimentelle Medizin, 1988
- PentoxifyllineDrugs, 1987